This learning plan reviews appropriate treatment options for acute and chronic anterior uveitis, including corticosteroid therapy and its risks and benefits, as well as immunomodulatory therapy. The plan is based on IRIS Registry measure IRIS51, Acute Anterior Uveitis: Posttreatment Visual Acuity, and measure IRIS53, Chronic Anterior Uveitis: Posttreatment Visual Acuity.